Moderna Whale Trades Spotted A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 14 strange trades. Benzinga · Aug 8, 2022
Looking At Moderna's Recent Whale Trades Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Benzinga · Aug 5, 2022
Looking At Moderna's Recent Whale Trades Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Benzinga · Jul 29, 2022
This Is What Whales Are Betting On Moderna Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Benzinga · Jul 27, 2022
Moderna Whale Trades Spotted A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 23 strange trades. Benzinga · Jul 19, 2022
Check Out What Whales Are Doing With MRNA Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Benzinga · Jul 18, 2022
Moderna Whale Trades Spotted Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Benzinga · Jul 11, 2022
This Is What Whales Are Betting On Moderna Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Benzinga · Jul 5, 2022
What Are Whales Doing With Moderna A whale with a lot of money to spend has taken a noticeably bullish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 19 strange trades. Benzinga · Jul 1, 2022
What Are Whales Doing With Moderna A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 13 strange trades. Benzinga · Jun 27, 2022
This Is What Whales Are Betting On Moderna Someone with a lot of money to spend has taken a bullish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Benzinga · Jun 22, 2022
Moderna's Bivalent COVID-19 Booster Shows Antibody Response Against Omicron Subvariants Moderna Inc (NASDAQ:MRNA) has released new clinical data on its bivalent (omicron) COVID booster candidate, mRNA-1273.214. One month after administration in previously vaccinated and boosted participants, a 50 µg booster dose of mRNA-1273.214 elicited potent neutralizing antibody responses against the omicron subvariants BA.4 and BA.5. The company is working on completing regulatory submissions… Benzinga · Jun 22, 2022
Moderna To establish New Vaccine Facility In Britain Moderna Inc (NASDAQ:MRNA) announced an agreement with the United Kingdom government to establish an mRNA Innovation and Technology Center in the U.K. Additionally, Moderna plans to expand its presence in the U.K. through investments in R&D activities. Moderna is collaborating with the National Institute for Health Research on a Phase 3 study… Benzinga · Jun 22, 2022
Looking At Moderna's Recent Whale Trades Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Benzinga · Jun 17, 2022
Benzinga · Jun 16, 2022 Moderna Plans COVID-19 Vaccine Trial For Infants: WSJ Moderna Inc (NASDAQ: MRNA) is reportedly planning to evaluate its COVID-19 vaccine in infants aged three months to 6 months.
Benzinga · Jun 15, 2022 $100 Invested In This Stock 10 Years Ago Would Be Worth $3,600 Today Moderna (NASDAQ:MRNA) has outperformed the market over the past 10 years by 32.14% on an annualized basis producing an average annual return of 42.94%. Currently, Moderna has a market capitalization of $49.53 billion.
Benzinga · Jun 15, 2022 FDA Committee Backs Moderna's COVID-19 Shot For Kids, Adolescents: Report Moderna Inc's (NASDAQ: MRNA) COVID-19 vaccine received unanimous backing from the FDA's committee of independent immunization experts for children ages 6 through 17.
Benzinga · Jun 14, 2022 Moderna's COVID-19 Shot Likely Related To Higher Heart Inflammation Risk Than Pfizer's: Reuters Moderna Inc's (NASDAQ:MRNA) COVID-19 vaccine may relate to a higher risk of heart inflammation in some age groups than Pfizer Inc (NYSE:PFE) - BioNTech SE's (NASDAQ:BNTX) shot, Reuters reported citing the Centers for Disease Control and Prevention. Citing recent data, CDC said that the findings on myocarditis and pericarditis, types of heart inflammation linked to both the…
Benzinga · Jun 13, 2022 Looking At Moderna's Recent Whale Trades Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Benzinga · Jun 9, 2022 Why Moderna Stock Is Moving Lower Today Moderna Inc (NASDAQ: MRNA) shares are trading lower Thursday as vaccine stocks fall in sympathy with Novavax Inc (NASDAQ: NVAX) following reports the FDA's decision on the company's COVID-19 vacci
Benzinga · Jun 9, 2022 US Schedules Covid-19 Vaccines For Children Below Five Years The U.S. government is preparing to launch vaccines for children below five in conjunction with educational and outreach efforts, pending approval by federal regulators, the Wall Street Journal reports. The government looks to provide ten million initial doses as the virus spreads nationwide, leaving the parents anxious. The vaccinations could begin…
Benzinga · Jun 8, 2022 Moderna's Updated COVID-19 Shot Boosts Omicron Protection Moderna Inc (NASDAQ: MRNA) has
Benzinga · Jun 7, 2022 Expert Ratings for Moderna Within the last quarter, Moderna (NASDAQ:MRNA) has observed the following analyst ratings:
Benzinga · Jun 7, 2022 Moderna Commences Late-stage Study of Flu Vaccine Candidate Moderna, Inc. (NASDAQ: MRNA) today announced Initiation of Patient dosing in the phase 3 clinical study of its seasonal influenza vaccine candidate mRNA-1010 for patients with influenza.
Benzinga · Jun 1, 2022 Check Out What Whales Are Doing With MRNA Someone with a lot of money to spend has taken a bullish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.